Merger Roundup: August 26, 2013 - Presented by: The Aol. On Network

Amgen (AMGN) and Onyx Pharmaceuticals (ONXX) announced they have approved a transaction under which Amgen will acquire all of the outstanding shares of Onyx for $125 per share in cash. The purchase price is $10.4 billion, or $9.7 billion net of estimated Onyx cash.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 15.7699 0.27 ▼ 1.68%
JCP $ 8.845 0.28 ▼ 3.02%
AAPL $ 129.965 0.45 ▼ 0.35%
GE $ 26.225 0.34 ▲ 1.29%
PBR $ 6.635 0.35 ▲ 5.48%
TVIX $ 2.035 0.05 ▼ 2.16%
ARCP $ 9.93 0.70 ▲ 7.58%
HPQ $ 34.86 0.85 ▲ 2.50%

As of 2/27/2015, 12:24 PM
More Most Active